The relationship between serum progesterone level on the day of HCG trigger in IVF/ICSI cycles and oocyte maturation and embryo quality: a retrospective observational study
- PMID: 39736583
- PMCID: PMC11684037
- DOI: 10.1186/s12905-024-03535-9
The relationship between serum progesterone level on the day of HCG trigger in IVF/ICSI cycles and oocyte maturation and embryo quality: a retrospective observational study
Abstract
Purpose: Previous studies have suggested a link between serum progesterone levels on the day of the HCG trigger in IVF cycles and oocyte and embryo quality. This study aims to explore this relationship more thoroughly.
Methods: This study included 496 infertility patients at Moloud Infertility Treatment Center, Zahedan, Iran. Statistical methods were used to assess factors such as oocyte maturation and embryo quality, fertilization rate, BMI, and gonadotropin dosage.
Results: While an initial progesterone cutoff of 1.2 ng/ml was used to perform fundamental analysis, a more accurate cutoff of 1.54 ng/ml was identified, beyond which the average number of M1 oocytes significantly declined. A strong relationship was found between higher progesterone levels and a greater number of retrieved oocytes (p = 0.004), with M1 oocytes showing a similar relation. Also, BMI was significantly related to the quality of eight-cell grade B embryos (p = 0.006). However, no significant correlations were found between progesterone levels and other factors, including patient age (p = 0.327), fertilization rate (p = 0.603), or embryo quality at other stages.
Conclusions: The findings demonstrate that elevated progesterone level, particularly beyond the identified cutoff of 1.54 ng/ml, is a valuable clinical indicator of suboptimal IVF outcomes due to its negative impact on oocyte maturation.
Keywords: Embryo quality; HCG trigger; IVF; Infertility; Oocyte maturation; Progesterone.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Ethical approval: The studies involving human participants were reviewed and approved by the Zahedan University of Medical Sciences Ethics Committee and were conducted according to the guidelines on human experimentation of the 1975 Declaration of Helsinki. The patients/participants provided their written informed consent to participate in this study. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures
References
-
- Allen C, McLernon D, Bhattacharya S, Maheshwari A. Early pregnancy outcomes of IVF cycles using donor versus partner sperm: analysis of 1,376,454 cycles recorded by the Human Fertilisation and Embryology Authority (1991–2016). Hum Reprod. 2023;38(6):1194–201. - PubMed
-
- Mahran A, Khairy M, Elkhateeb R, Hegazy AR, Abdelmeged A, Batiha GE, et al. The value of serum progesterone level on the day of human chorionic gonadotropin administration/metaphase II oocyte ratio in predicting IVF/ICSI outcome in patients with normal ovarian reserve. J Ovarian Res. 2021;14(1):52. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
